Shares of biopharmaceutical drug delivery company Halozyme Therapeutics (NASDAQ:HALO) jumped 5.2% in the afternoon session ...
Canada is the first G7 country to approve the lower cost weight-loss drugs, which are rolling out in pharmacies this month.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results